CLINICAL_TRIALS
trial_result
· 2013-11-01
Clinical Trial Update: Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS) [Phase 2]
Summary
A Phase 2 dose-finding study of pramipexole (Sifrol) for idiopathic restless legs syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Restless Legs Syndrome | Phase 2 | Status: COMPLETED